ProPhase Labs, Inc. (OTC: PRPH) (“ProPhase” or the “Company”) is pleased to invite investors to a webinar on Tuesday, February 3, 2026, at 4:15 p.m. ET. The exclusive event, hosted by RedChip ...
During this transformative phase to right size and focus the laboratory operations, ProPhase faced numerous one-time charges, including more than $2.4 million in startup costs. It also equipped Nebula ...
Crown Medical Collections (“Crown Medical”), which serves as special counsel to the Debtors for the collection of accounts receivable, is actively engaged in settlement negotiations with a broad group ...
Oocytes are arrested for long periods of time in the prophase of the first meiotic division (prophase I). As chromosome condensation poses significant constraints to gene expression, the mechanisms ...
ProPhase Labs' recent 52-week low is reflective of broader challenges faced by the company, as highlighted by several InvestingPro metrics and tips. The company's market capitalization stands at a ...
ProPhase Labs announced plans to launch DNA Complete and DNA Expand, scale up operations at PMI, and implement cost reduction plans. The company aims to reduce overhead costs by $6 million, which ...
Actin is a multi-functional protein that is involved in numerous cellular processes including cytoskeleton regulation, cell migration, and cellular integrity. In these processes, actin’s role in ...
(RTTNews) - ProPhase Labs, Inc. (PRPH), a next-generation biotech and consumer products company, Thursday announced two key initiatives to strengthen its financial position and generate significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results